Soto, J.A., Melo-González, F., Gutierrez-Vera, C., Schultz, B.M., Berríos-Rojas, R.V., Rivera-Pérez, D., Piña-Iturbe, A., Hoppe-Elsholz, G., Duarte, L.F., Vázquez, Y., Moreno-Tapia, D., Ríos, M., Palacios, P.A., Garcia-Betancourt, R., Santibañez, Á., Mendez, C., Diethelm-Varela, B., Astudillo, P., Calvo, M., Cárdenas, A., González, M., Goldsack, M., Gutiérrez, V., Potin, M., Schilling, A., Tapia, L.I., Twele, L., Villena, R., Grifoni, A., Sette, A., Weiskopf, D., Fasce, R.A., Fernández, J., Mora, J., Ramírez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverría, F., Soto-Rifo, R., Retamal-Díaz, A., Muñoz-Jofré, N., Meng, X., Xin, Q., Alarcón-Bustamante, E., González-Aramundiz, J.V., Le Corre, N., Javiera Álvarez, M., González, P.A., Abarca, K., Perret, C., Carreño, L.J., Bueno, S.M., Kalergis, A.M., Group, 2022. An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile.. https://doi.org/10.1101/2022.02.15.22270973